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Abstract
Background: Quantification of late gadolinium enhanced cardiovascular magnetic resonance (LGE
CMR) by objective window setting increases reproducibility and facilitates multicenter comparison
and cooperation. So far, quantification methods or models have only been validated to postmortem
animal studies. This study was undertaken to evaluate quantification of LGE in relation to the clinical
standard of viability, i.e. functional outcome after revascularization.
Thirty-eight patients with chronic ischemic myocardial dysfunction underwent cine and LGE 1
month before and cine CMR 6 months after coronary revascularization. Enhancement was
quantified by thresholding window setting at: 2-8SD above mean signal intensity of a remote normal
region, and according to the full width at half maximum method (FWHM). Dysfunctional segments
were divided in 5 groups according to segmental extent of enhancement (SEE): SEE 1 – no
enhancement to SEE 5 – 76–100% with each quantification method.
Results: Quantification methods had a strong influence on SEE and total infarct size. Multilevel
analysis showed that thresholding contrast images at 6SD best predicted segmental functional
outcome after revascularization, but the difference with other methods was small and non-
significant.
Conclusion: Simple thresholding techniques strongly influence global and segmental extent of
LGE, but have relatively little influence on the accuracy to predict segmental functional
improvement after revascularization.
Background
Revascularization of dysfunctional but viable myocar-
dium may lead to reversed remodelling, improved
regional and global function and better prognosis in
patients with chronic ischemic heart disease [1]. The diag-
nostic accuracy of imaging modalities to predict func-
tional outcome is influenced by the definition of disease
(what is viable). Although visual or qualitative analysis
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quantification of these definitions increases reproducibil-
ity and reliability in follow-up studies, and facilitates
comparison between different centers.
Late gadolinium enhanced cardiovascular magnetic reso-
nance (LGE CMR) accurately visualizes the transmural
extent of ischemia-related scar and has been shown to pre-
dict the likelihood of functional improvement after revas-
cularization [2,3]. Several methods have been proposed to
differentiate enhanced, non-viable from non-enhancing,
viable myocardium, all using the in-slice signal intensity
of infarcted or remote myocardium, and ranging from
simple thresholding to more complex computer algo-
rithms. We have previously shown that the use of com-
mon thresholds based on the suppressed signal of remote
myocardium may lead to considerable overestimation of
the infarct size [4]. However, in this study, we used visual
estimation as the reference standard. Although a number
of experimental studies have used ex-vivo imaging or
2,3,5-triphenyltetrazolium choride (TTC) staining to
determine the optimal threshold of enhancement, so far,
no study has used the clinically useful standard of viability
i.e. functional outcome after revascularization [5-7].
Therefore, the aim of this study was to evaluate the rela-
tion between quantification of LGE and functional out-
come after revascularization in patients with chronic
ischemic myocardial dysfunction. To quantify LGE, we
chose simple thresholding techniques that are easily
applicable in any clinical or research situation.
Methods
Patients
All patients with known coronary artery disease and
regional wall motion abnormalities on echocardiography
or left ventricular (LV) angiography, without CMR con-
traindications, who were scheduled to undergo surgical or
percutaneous revascularisation, were study candidates.
The Committee on Research Involving Human Subjects of
the VU University Medical Centre, Amsterdam, approved
the study protocol. All patients gave written informed
consent.
Forty-seven patients were initially included in this study
protocol. After revascularization, 7 patients were excluded
because of left ventricular aneurysmectomy (1), electro-
cardiographic and/or biochemical evidence of peri-proce-
dural myocardial infarction (defined as post procedural
peak CK-MB > 3 upper limit of normal) (4), pacemaker
implantation (1), and incomplete data (1). During analy-
sis, 2 more patients were excluded because of absence of
wall motion abnormalities at baseline and non-diagnostic
image quality, leaving 38 patients as the final study group.
All patients were in stable clinical condition at the time of
both CMR examinations without clinical evidence of
ischemic events during the study period.
CMR
CMR scans were acquired at 4 ± 4 weeks before and 30 ±
4 weeks after revascularisation. All scans were performed
on a 1.5T scanner (Sonata, Siemens, Erlangen, Germany)
with the patient in a supine position using a four-element
phased array cardiac receiver coil. ECG-gated cine images
were acquired using a breath-hold segmented steady-state
free precession sequence (true FISP; echo time/repetition
time of 1.2/3.2 ms; resolution of 1.3 × 1.8 × 5 mm). Per
patient eight to ten short-axis views were obtained every
10 mm starting from the mitral valve insertion and cover-
ing the entire left ventricle. Ten to 15 minutes after injec-
tion of a gadolinium-based contrast agent (Magnevist,
Schering AG, Berlin, Germany; 0,2 mmol/kg) contrast-
enhanced images were acquired in the same orientation as
the cine images using a 2D-segmented inversion recovery
gradient-echo pulse sequence triggered to end-diastole
(repetition time/echo time = 9.6/4.4 ms, flip angle 25°,
inversion time set to suppress signal from remote myocar-
dium, matrix 208 × 256 and a typical voxel size of 1.6 ×
1.3 × 5.0).
Data analysis
All data were analysed on a separate workstation using a
dedicated software package (MASS v15, 2008, Medis, Lei-
den, The Netherlands).
Segmental function
Segmental wall thickness was measured at end-systole and
end-diastole after manual tracing of endocardial end epi-
cardial borders in stop-frame images, carefully excluding
trabeculations and papillary muscles. The observer (OB)
was blinded to other patient or imaging data such as
extent of coronary artery disease, use of medication and
results of the LGE analysis. Baseline and follow-up slices
were analysed separately after registration using the scan-
ner slice position and various anatomical landmarks such
as right ventricle septal insertion sites, papillary muscle
location, and trabecularization patterns in the right and
left ventricles. Although the observer was unaware of the
timing of the study, blinding to pre-/postoperative status
was impossible because of the artifacts related to sternal
wires. For segmental analysis, the 2 most basal and apical
slices were excluded because of the left ventricular outflow
tract and partial volume effects, respectively. The remain-
ing slices were divided into 6 segments each, starting at
the inferior insertion of the right ventricle to the septum.
Segmental wall thickening (SWT) in millimetres was cal-
culated as: end systolic wall thickness minus end diastolic
wall thickness. Segments with SWT < 3 mm (mean – 2SD)
were considered dysfunctional [4]. Functional improve-Page 2 of 7
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pared to baseline. Intraobserver and interobserver
variability of SWT were 0.0 ± 0.4 mm (mean difference
between 2 measurements (OB); intraclass correlation
coefficient = 0.97, 95% confidence interval 0.86 – 0.99),
and 0.1 ± 0.7 mm (mean difference between values of
observer 1 (OB) and 2 (AMB); intraclass correlation coef-
ficient = 0.89, 95% confidence interval 0.55–0.98), as
reported previously [3].
Global function
Left ventricular end-diastolic volume (EDV) and end-
systolic volumes (ESV) were determined by planimetry of
all short-axis images in each patient and indexed to body
surface area. Left ventricular ejection fraction (EF, %) was
calculated as (LVEDV - LVESV)/LVEDV * 100%.
Enhancement
Endocardial and epicardial contours were manually
traced, again avoiding papillary muscles and trabeculari-
zations. Enhanced regions were then determined in the
following ways:
I. After thresholding signal intensity at 2–8 standard devi-
ations (SD) above the mean signal intensity of remote
normal myocardium in the same slice. A region of interest
of 0.5–1 cm2 was manually drawn and placed in remote
normal myocardium (defined as normal function without
enhancement on visual assessment). If a slice contained
no remote normal myocardium, mean and SD of the
nearest slice with normal remote myocardium was used;
if the 2 neighbouring slices contained normal myocar-
dium, mean and SD were averaged.
II. After thresholding signal intensity using the full-width
at half-maximum (FWHM) method that defines the
enhanced area by using 50% of the maximum signal
found within the enhanced area. The maximum signal
was found by computer-assisted window thresholding of
the enhanced area. If no enhancement was found in a
slice, the maximum signal of the nearest slice with
enhancement was used; if the 2 neighbouring slices
showed enhancement, maximum signals were averaged.
All areas of enhancement were quantified by computer-
assisted planimetry on each of the short axis images and
segmental extent of enhancement (SEE) was expressed as
percentage of segmental area. Obvious artifacts such as
caused by motion were excluded by highlighting them
using a tool from the software package. Other small iso-
lated regions of enhancement that were clearly not of
ischemic origin (like small subepicardial spots) were also
excluded from analysis. Total infarct size was calculated
by summation of all slice volumes of enhancement, i.e.
including the slices that were excluded for segmental anal-
ysis.
Statistical analysis
The paired sample t test (with Bonferroni correction) and
the independent samples t test were used to compare
means within the study group or between subgroups. To
account for the non-independence of the data, we used
multilevel logistic regression (MlwiN, version 1.02.0007,
Centre for Multilevel Modelling, London, United King-
dom) to analyse the relation between SEE and the likeli-
hood of improvement. Details of the multilevel analysis
have been published previously [3]. All dysfunctional seg-
ments were assigned to one of the following groups
according to SEE: 1 – 0%, 2 – 1 to 25%, 3 – 26 to 50%, 4
– 51 to 75%, and 5 – 76 to 100% enhancement. The
regression coefficients were used to calculate odds ratios
that express the likelihood of improvement of SEE-groups
2–5 relative to SEE-group 1. To compare the different
quantification methods, multilevel analysis was repeated
assuming a linear correlation between SEE and likelihood
of improvement, which generates one regression coeffi-
cient per method.
Receiver operating characteristics (ROC) analysis was
used to find the SEE cut-off with highest diagnostic accu-
racy to predict segmental functional improvement.
Improvement in ejection fraction was defined as an
increase from baseline to follow-up of ≥ 5%. Since the
number of viable segments per patient is not normally
distributed, the Mann-Whitney test was used to compare
these between patients with and without improved ejec-
tion fraction.
All values are expressed as mean ± SD. P-values < 0.05
were considered statistically significant.
Results
Patient characteristics are provided in table 1.
Extent of enhancement
The extent of enhancement according to quantification
method is shown in table 2. Both total infarct size and seg-
mental extent of enhancement were strongly correlated
between all methods (p < 0.001), except total infarct size
between FWHM and 2SD and 3SD (non-significant after
Bonferroni correction). Total infarct size decreased with
increasing number of SD's (all steps p < 0.001). Total inf-
arct size according to FWHM differed significantly from
2–4 SD (p < 0.001). Mean SEE decreased with increasing
number of SD's and FWHM (all p < 0.001).Page 3 of 7
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A total of 1122 segments were analysed (29.6 ± 5.5/
patient). Of these, 628 were dysfunctional (mean SWT 1.1
± 1.1 mm). Segmental function improved in 174 seg-
ments (mean SWT 0.9 ± 1.2 to 3.5 ± 1.5 mm). The likeli-
hood of improvement was inversely related to the SEE
according to all quantification methods. The results of the
multilevel analysis are displayed in table 3. The odds
ratios were inverted so that they reflect the number of
times that a certain SEE group is less likely to improve
compared to SEE group 1 in that category. Quantifying
enhancement using 6SD best predicted segmental func-
tional improvement at follow-up: segments in SEE-groups
2, 3, 4 and 5 were 2.7, 4.7, 5.2 and 14.8 less likely to
improve than segments in SEE-group 1 (table 3).
Multilevel analysis was repeated assuming a linear rela-
tionship between SEE-groups and likelihood of improve-
ment. This analysis generates one odds ratio that
represents the likelihood of improvement from one SEE-
group to the next. 6SD had the highest predictive power:
SEE-group x was 2.04 (95% confidence intervals 1.62–
2.58) less likely to improve than the SEE-group x-1. 2SD
had the lowest power with (inverted) odds ratio 1.66
(1.31–2.08). Figure 1 shows 95%-confidence intervals for
each method, demonstrating that there is considerable
overlap.
Left ventricular EDV and ESV were 123 ± 36 ml/m2 and
79 ± 35 ml/m2 at baseline, and decreased significantly to
108 ± 36 ml/m2 (p < 0.001) and 68 ± 35 ml/m2 (p =
0.002), respectively. Mean EF improved from 38.2 ±
11.4% at baseline to 40.4 ± 12% at follow-up (p = 0.067).
ROC analysis showed that the 6SD method optimally pre-
dicted segmental improvement at < 10% SEE (AUC 0.700
(0.654–0.746), sensitivity 70%, specificity 65%) (table
4). Twenty-two patients showed significant (≥ 5%)
improvement in EF. Although the number of dysfunc-
tional segments with < 10% SEE-6SD was higher in
patients with improved ejection fraction compared to
patients without improvement (median 7.5, range 1–24,
vs 4.0, range 0–14), there was considerable overlap, and
no significant difference could be found (Mann-Whitney-
test, p = 0.251).
Discussion
Our results show that quantification methods have a
strong influence on total and regional infarct extent.
Although analysis using 6SD above signal intensity of a
remote normal region resulted in the best prediction of
segmental functional improvement after revasculariza-
tion, differences with the other methods were small and
non-significant.
LGE quantification
Both SD- and FWHM-methods are based on experience
rather than on firm pathophysiological evidence. SD uses
Table 1: Patient characteristics
Number of patients 38
Age (sd) 62 (10)
Men 33 (87%)
Diabetes 10 (26%)
Hypercholesterolemia 7 (18%)
Hypertension 8 (21%)
Smoking 4 (11%)
1-vessel disease 10 (26%)
2-vessel disease 24 (63%)
Medication
Aspirin 22 (58%)
Acenocoumarol 16 (42%)
Betablockers 29 (76%)
Statins 29 (76%)
Ace-inhibitors 20 (53%)
PCI* 9 (24%)
CABG* 30 (76%)
Mean nr grafts (sd) 3,6 (1,1)
* percutaneous coronary intervention.
** coronary artery bypass grafting.
Table 2: Global and segmental extent of enhancement according to quantification
2SD 3SD 4SD 5SD 6SD 7SD 8SD FWHM
TIS 31.3 (12.1) 23.6 (11.6) 18.7 (11.5) 15.7 (11.1) 12.6 (9.1) 10.4 (8.9) 7.9 (6.8) 14.1 (6.8)
SEE* 36.2 (31.9) 29.2 (31.0) 24.3 (29.5) 20.9 (27.9) 17.9 (25.8) 15.8 (24.4) 14.1 (23.3) 15.4 (22.4)
TIS = mean (sd) total infarct size. SEE = mean (sd) segmental extent of enhancement.
* = dysfunctional segments only. Statistical analysis see text.Page 4 of 7
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region, whereas FWHM uses the peak signal within the
enhanced region. FWHM has been suggested on theoreti-
cal grounds to be less sensitive to partial volume effects.
Amado et al compared total infarct size according to the
SD- and FWHM-thresholding methods and postmortem
data in an animal occlusion-reperfusion study [5]. They
found that FWHM correlated best with TTC-staining with
a small overestimation (significance not reported),
whereas no significant correlation and considerable over-
estimation was found with 6SD. Heiberg et al recently
proposed a quantification method to compensate for par-
tial volume effects in thicker (8–10) mm) slices by weight-
ing pixels according to their signal intensity [7]. The
standard LGE protocol in our institution uses 5 mm slice
thickness, which maintains excellent image quality while
minimizing partial volume effects.
Hsu et al developed a computer algorithm based on fea-
ture analysis and combined thresholding involving
sequential use of the 2SD- and FWHM-method [6]. The
algorithm was validated in a canine study, and compared
to visual assessment and 2SD- and FWHM-thresholding
using ex-vivo and in-vivo LGE. The authors found that inf-
arct size measured by their model showed no difference
with TTC-staining, and was more accurate than the other
methods, that all overestimated the histopathological inf-
arct size. The algorithm was subsequently tested in 20
patients with acute or chronic infarction, and resulted in
significantly lower values for both regional and global inf-
arct size when compared to visual assessment, although
this study lacked a reference standard [9]. Hsu et al used
phase-sensitive reconstruction in both studies and also
used 8 mm slice thickness, which makes comparison of
their findings to our study difficult and again stresses the
importance of standardization.
In a previous study we quantified enhancement in 15
patients with chronic ischemic heart disease. In compari-
son to visual assessment, we found significant overestima-
tion with 2–4SD of both segmental extent and total
infarct size [4]. The use of 6SD led to a significant under-
estimation, whereas 5SD showed no difference.
In the current study we used functional outcome after
revascularisation as the clinical reference standard of via-
bility. We found that, although the extent of enhancement
was profoundly influenced by the quantification method
used, there was no significant difference in their accuracy
to predict segmental functional improvement at follow-
up. 6SD showed the highest accuracy, followed closely by
FWHM, 4SD and 5SD. Thresholding at 2SD and 3SD
above remote signal intensity was less accurate, but there
was still considerable overlap of confidence intervals with
6SD. Our data suggest that simple thresholding methods
using the signal intensity of remote or of the enhanced
area have relatively little effect on the assessment of
regional viability and the prediction of likelihood of
improvement. The lack of a clear difference may seem sur-
prising considering the large differences that the use of the
various methods caused in total infarct size and segmental
extent of enhancement. However, with each method the
inverse relation between SEE and likelihood of improve-
ment remains intact, which makes it hard to detect small
differences in predictive power. A larger study group and
longer follow-up may be required to strengthen the statis-
tical position of 6SD [3].
Limitations
All current LGE quantification methods are limited by the
fact that essential steps like the delineation of myocardial
contours, the drawing a region of interest in remote myo-
cardium and the exclusion of artifacts are all (still) done
manually.
The applicability of our results is limited to patients with
chronic ischemic heart disease, although they are proba-
bly valid in acute myocardial infarction, since both ani-
mal and clinical studies have shown that enhancement
reflects necrosis at all stages after infarction [10-12]. How-
ever, this remains to be established. Also, our results can-
not be extrapolated to other techniques (e.g. 3D-
acquisition) or scanner types (especially with different
magnetic field strengths).
In conclusion, in this study we evaluated the relation
between simple thresholding techniques to quantify LGE
images and functional outcome after revascularization in
Table 3: Likelihood of improvement versus quantification.
SEE 1 SEE 2 SEE 3 SEE 4 SEE 5
2SD 1 0,7 1,2 2,0 2,5
3SD 1 1,6 3,8 3,8 5,2
4SD 1 1,3 1,5 3,4 4,5
5SD 1 1,5 3,1 4,3 6,1
6SD 1 2,9 4,7 5,2 14,8
7SD 1 2,0 4,4 3,9 10,8
8SD 1 2,1 4,1 3,2 9,6
FWHM 1 2,4 3,5 4,7 5,5
SEE = segmental extent of hyperenhancement. Numbers represent 
odds ratios of likelihood of improvement of SEE 2–5 versus SEE 1, 
which is set at 1.Page 5 of 7
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Although quantitative analysis with window setting
thresholded at mean + 6SD of the signal of a remote nor-
mal region best predicted segmental functional improve-
ment, there was no significant difference with the other
SD or FWHM methods. Further study is needed to evalu-
ate SD and FWHM in larger groups with a longer follow-
up and compare them to the more complex algorithms
that have not yet been tested in human viability studies.
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Multilevel analysis assuming linear relation between likelihood of improvement according and quantification methodFigur  1
Multilevel analysis assuming linear relation between likelihood of improvement according and quantification 
method. (Inverted) odds ratios and 95%-confidence intervals according to quantification method. See text for further explana-
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Table 4: Sensitivity and specificity to quantification method.
sens spec SEE*
2SD 0,72 0,55 28
3SD 0,72 0,57 21
4SD 0,64 0,65 25
5SD 0,68 0,64 14
6SD 0,70 0,65 9
7SD 0,65 1,00 9
8SD 0,65 1,00 7
FWHM 0,61 0,66 9
* = segmental extent of enhancement (%) at optimal sensitivity and 
specificity.Page 6 of 7
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